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The Raf family of serine/threonine kinases are essential components in many receptor tyrosine kinase-mediated signal
transduction pathways. Here, we analyze the function of D-raf in the Torso (Tor) pathway required to specify cellular fates
at the embryonic poles. Using mutant embryos lacking endogenous D-raf protein, we show that D-raf's serine/threonine
kinase activity is essential for its role in Tor signal transduction and that human Raf-1 will substitute for D-raf in this
pathway. After Tor activation, D-raf becomes hyperphosphorylated. We identi®ed two putative serine phosphorylation
sites (S388 and S743) in SF9 cells and demonstrate that S743 or its phosphorylation is essential for D-raf function in
embryos. Alanine substitution at S388, N-terminal truncation, or targeted membrane association permits transmission of
the Torso signal by D-raf, but these D-raf molecules differ in their rescuing potential and relative biological activity.
Membrane-targeted D-raftor4021 showed the highest level of activity, followed by alanine-substituted D-rafS388A and N-
terminal-truncated D-rafD445. Since the activity pro®les for these altered forms of D-raf are distinct, these ®ndings indicate
that each structural modi®cation differentially affects the regulation and/or propagation of the Tor signal by these mutant
D-raf proteins. q 1996 Academic Press, Inc.
INTRODUCTION tion factors, tailless (Pignoni et al., 1990) and huckebein
(Weigel et al., 1989; BroÈnner and JaÈckle, 1991), which are
required for development of the embryonic head and tail.Polarity along the anterior±posterior axis of the Drosoph-
The Tor protein is evenly distributed along the embryonicila embryo is established by the activity of maternal gene
membrane (Casanova and Struhl, 1989). Spatially restrictedproducts deposited into the egg during oogenesis. These ac-
activation of Tor relies upon factors encoded by the fs(1)tivities direct specialized domains of zygotic gene expres-
Nasrat (Degelmann et al., 1986), fs(1) pole hole (Perrimonsion important for the determination of cellular fates (for
et al., 1986), torso-like (Stevens et al., 1990; Savant-Bhon-review see Klinger, 1990; NuÈ sslein-Volhard, 1991; St. John-
sale and Montell, 1993; Martin et al., 1994), and trunk (Cas-ston and NuÈ sslein-Volhard, 1992). Spatial information at
anova et al., 1995) genes. Since these products act upstreamthe termini, or embryonic poles, is transferred to nuclei
of Tor, they are likely to play key roles in the production,through the activity of the Torso (Tor) signal transduction
accessibility, and spatial distribution of the Tor ligand.pathway (for review see Lu et al., 1993b). Localized activa-
Once Tor is activated along the syncytial membrane at thetion of the Tor receptor tyrosine kinase (RTK) (Sprenger and
embryonic poles, its signal is transduced to underlying nu-NuÈ sslein-Volhard, 1992) leads to expression at the embry-
clei by an evolutionarily conserved set of proteins (see Perri-onic poles of zygotic genes encoding the putative transcrip-
mon, 1993) that include D-ras1 (Lu et al., 1993a) and the
protein kinases D-raf (Nishida et al., 1988; Ambrosio et al.,
1989a), D-MEK (Tsuda et al., 1993; Hsu and Perrimon, 1994;1 To whom correspondence should be addressed.
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Lu et al., 1994), and MAP kinase (Biggs and Zipursky, 1992; tion conserved in all Raf family members, is essential for
Raf-1 activity (Morrison et al., 1993; Fabian et al., 1993).Biggs et al., 1994; Brunner et al., 1994). It is through the
activity of this phosphorylation cascade that the fate of nu- We have utilized the Tor pathway to learn about the regu-
lation of D-raf and its signal transduction by microinjectionclei at the poles is determined.
How the activity of D-Raf is regulated in this or other of D-raf mRNAs into Drosophila embryos. As a single large
cell at early stages of embryogenesis, the Drosophila em-RTK-mediated signal transduction pathways, such as the
sevenless or EGF-receptor pathways in Drosophila (Dickson bryo serves as an in vivo system in which to assay the
activity and biological function of various D-raf proteins.et al., 1992; Brand and Perrimon, 1994), is not well under-
stood at this time. Since at the amino acid level there is In the absence of D-raf-mediated Tor signal transduction,
the embryonic head and tail fail to develop. Rescue of this45% homology between D-raf and the human Raf-1 proto-
oncogene (Mark et al., 1987; Nishida et al., 1988), regulation defect by microinjection of wild-type and mutant D-raf
mRNAs is used to assess whether propagation of the Torof D-raf's activation and activity is likely similar to that of
Raf-1. In mammalian cells, the Raf-1 kinase is regulated by signal has been achieved by these forms of D-raf. Here, we
examine their effects without interference from endogenousmultiple mechanisms. Activation of Raf-1 after stimulation
of cells with growth factors is accompanied by association D-raf by preparing mutant embryos lacking maternal D-raf
protein. We tested wild-type and modi®ed D-raf proteinsof Raf-1 with Ras (Moodie et al., 1993; Van Aelst et al.,
1993; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., with serine substitutions that alter sites of phosphorylation
in Sf9 cells, N-terminal truncations, a membrane-associated1993; Pumiglia et al., 1995), the translocation of Raf-1 to
the plasma membrane (Leevers et al., 1994; Stokoe et al., D-raf fusion protein, and human Raf-1 to characterize their
activity in the Tor signaling pathway.1994), and hyperphosphorylation of Raf-1 (Morrison et al.,
1988, 1989). In addition, Raf-1 can associate with other pro- We ®nd that D-raf's serine/threonine kinase activity is
essential for rescue of terminal defects in embryos lackingteins including hsp 90, p50 (Stancato et al., 1993; Wartmann
and Davis, 1994), Fyn, Src (Williams et al., 1992; Cleghon maternal D-raf. We also show that human Raf-1 can interact
at low ef®ciency with Drosophila proteins to promote Torand Morrison, 1994), and 14-3-3 (Fantl et al., 1994; Freed et
al., 1994; Fu et al., 1994; Irie et al., 1994). Furthermore, it signal transduction in these embryos. In addition, we identi-
®ed two putative sites of D-raf phosphorylation in Sf9 cellshas also been demonstrated that Ras, Raf-1, and MEK can
form a ternary complex (Huang et al., 1993, 1994; Moodie and show that one, serine S743, is essential for D-raf func-
tion in the Tor pathway. Alternatively, alanine substitutionet al., 1993; Van Aelst et al., 1993; Jelinek et al., 1994) and
is likely to exist as a member of a multiprotein complex(es) at residue S388 (D-rafS388A) did not inhibit D-raf's ability
to act in Tor signal transduction. Also, we show that N-(Morrison, 1994). Based upon the complexity of regulation
for Raf-1, it is probable that in Drosophila the mecha- terminal-truncated D-rafD315, D-rafD370, D-rafD445, and a
membrane-targeted D-raftor4021 can participate in Tor signal-nisms(s) utilized to regulate D-raf's activity in Tor, as well
as in other RTK-mediated signal transduction pathways, is ing. However, the biological activities of these mutant D-
raf proteins, including D-rafS388A, are between 4- and 380-also complex.
D-raf shares with other Raf family members three regions fold greater than wild type, indicating that these structural
modi®cations may distinctly alter the regulation and/orof high amino acid conservation important for its regulation
and activity (CR1, CR2, and CR3). CR1, located within the propagation of the Tor signal by D-raf.
N-terminal domain of the protein, mediates Raf-1 interac-
tion with Ras and its membrane localization. Disruption of
CR1 by mutation at Arg89 prevents Raf-1 association with MATERIALS AND METHODS
Ras and Ras-mediated activation of Raf-1 (Fabian et al.,
1994), while mutation within the cysteine ®nger motif Drosophila Strains
(C152X2CX9CX2C168) at Cys168 attenuates interaction be-
In this study, wild-type Oregon R (Lindsley and Zimm, 1992) andtween Raf-1 and Ras (Kolch et al., 1993; Bruder et al., 1992).
the D-raf11-29 allele (Ambrosio et al., 1989b; Melnick et al., 1993)For D-raf, Arg89 corresponds to Arg217, and mutation of this were used. To generate germline clones of D-raf11-29, the ``FLP-DFS''
residue leads to a partial loss of D-raf function (Melnick et technique was utilized (Chou and Perrimon, 1992). Flies were raised
al., 1993). CR2 is a region rich in serine and threonine resi- on Drosophila medium at 257C under standard conditions (Roberts,
dues and contains Ser259, a major phosphorylation site of 1986; Weischaus and NuÈ sslein-Volhard, 1986; Ashburner, 1989).
Raf-1 (Morrison et al., 1993). Mutation of Ser259 to Ala re-
sults in an increase in Raf-1 kinase activity in vitro and
Microinjectionsprevents its association with 14-3-3 (Michaud et al., 1995).
Thus, CR1 and CR2 appear to regulate Raf-1 function and Embryos were collected on molasses agar plates and microin-
furthermore, their deletion activates the transforming activ- jected with in vitro synthesized mRNA using the procedure of Baek
ity of Raf-1 (Stanton et al., 1989; Heidecker et al., 1990). and Ambrosio (1994). Embryos at stages nuclear cycle (NC) 6±9
CR3 is the substrate binding and kinase domain of the pro- were used for injection, and staging was according to Foe and Al-
berts (1983) and Campos-Ortega and Hartenstein (1985). After 48tein. Alteration of Ser621, an additional site of phosphoryla-
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hr at 197C, embryos were devitellinized with a sharp tungsten nee- (Chatsworth, CA). The DNAs were linearized, extracted with phe-
nol (pH 7.4), precipitated with 0.1 vol of 3 M sodium acetate anddle and Halocarbon oil (series 95, Halocarbon Products Corp.) was
removed from each embryo with heptane. These cuticular prepara- 1.5 vol of ethanol, and then dissolved in DEPC-treated distilled
water. mRNAs were generated using the mMESSAGE mMACH-tions of embryos were embedded in a (1:1) mixture of Hoyer's:lactic
acid according to van der Meer (1977) and photographed with a INE SP6 RNA polymerase kit from Ambion (Austin, TX) and then
dissolved in nuclease-free distilled water at 1.0 mg/ml.Zeiss Axioscope microscope using dark-®eld illumination or No-
marski optics. For in vitro translation, in vitro synthesized mRNAs were trans-
lated using a rabbit reticulocyte lysate kit (Amersham). Each reac-The D-raf gene is located on the X-chromosome and its product
is required at multiple stages of development. Without injection, tion contained 10 ml of reticulocyte lysate, 2 ml of 1 M potassium
acetate, and 1 mg of in vitro synthesized mRNA. Samples wereembryos that lack maternal D-raf protein show two phenotypic
classes (Ambrosio et al., 1989b). Male embryos that lack maternal incubated for 1 hr at 377C and analyzed by sodium dodecyl sulfate
(SDS)±polyacrylamide gel electrophoresis.and paternal D-raf protein show little cuticle differentiation and
are not considered in this analysis. Female embryos lack maternal
D-raf protein but inherit a paternal X-chromosome with a wild-
Expression of D-raf Proteins in Sf9 Cellstype copy of the D-raf gene. These female embryos are defective
only for the Tor signaling pathway. In our analysis, we address the
To obtain recombinant baculoviruses expressing mutant D-raf
question of posterior rescue for these female embryos. Thus, since
proteins, DNA fragments containing wild-type and mutant D-raf
the D-raf gene product acts in several different developmental path-
coding sequences were isolated using the restriction enzymes NcoI
ways, only its maternal role in the Tor pathway has been addressed
and EcoRI and were inserted into the corresponding sites in the
here.
pAcC4 baculoviral transfer vector. Each of the recombinant transfer
vectors was then cotransfected into Sf9 cells with wild-type AcNPVPlasmid Constructions
DNA, and recombinant baculoviruses were isolated by plaque puri-
Wild-type D-raf plasmid is as described by Sprenger et al. (1993); ®cation as described by Summers and Smith (1987).
Raf-1 is as in Fabian et al. (1993); and Raf-1D305 is as in Samuels et
al. (1993).
Site-directed mutagenesis. The plasmid pGEM7GLO was gen- Phosphopeptide Mapping
erated by inserting a 2.7-kb HindIII±EcoRI fragment from
For peptide mapping, 32P-labeled proteins isolated from Sf9 cellspSP64GLO, which contained the entire coding sequence of the D-
were separated by SDS±polyacrylamide gel electrophoresis (PAGE),raf gene (residues 1±782) inserted downstream of a 56-bp 5*-un-
eluted from the gel matrix, TCA precipitated, and subjected totranslated leader sequence from the Xenopus b-globin gene, into
enzymatic digestion with trypsin. Labeled polypeptides were sepa-the corresponding sites of plasmid pGEM7Z(0) (Promega). Single-
rated on thin layer cellulose plates by electrophoresis at pH 1.9 forstranded plasmid used for mutagenesis was produced from the plas-
27 min at 1000 V, followed by ascending chromatography in amid pGEM7GLO upon infecting host cells with the helper phage
buffer containing n-butanol:pyridine:acetic acid:water in a ratio ofM13K07 (Vieira and Messing, 1987). Oligonucleotides were synthe-
75:50:15:60.sized to generate the mutations K497M (5*-CCCGTGCCCGTA-
ATGACACTCAACGTG-3 *), S388A (5*-CAAGACGATCGATCC-
AATGCCGCGCCAAATGTG-3 *), and S743A (5*-CATCGCAGT-
Western Analysis of D-raf from MicroinjectedGCCGCTGAACCAAACTTG-3 *). Mutants were generated by the
Embryosmethod of Kunkel et al. (1987), as described by the vendor (for
Bio-Rad Mutagenesis Kit, Richmond, CA), and each mutation was Translation of injected mRNA in embryos was examined by
con®rmed by sequencing using a custom primer and the Sequenase Western blot analysis. After injection, the embryos were incubated
Version 2.0 DNA sequencing kit (United States Biochemical, at room temperature for 1 hr and then the Halocarbon oil was
Cleveland, OH). removed with heptane. To make extracts, the embryos were trans-
Deletion mutants. The deletion mutant D-rafD315 was gener- ferred into an Eppendorf tube and homogenized in lysis buffer con-
ated by removing a 0.9-kb NcoI fragment (encoding amino acids taining 1% Nonidet P-40, 20 mM Tris (pH 8.0), 137 mM NaCl,
1±315) from the construct pGEM7GLO and religating the plasmid. 10% glycerol, 2 mM EDTA, 1 mM phenylmethylsulfonyl ¯uoride,
Deletion mutants D-rafD370 and D-raftor4021 were generated as de- aprotinin (0.15 U/ml), 20 mM leupeptin at a concentration of 1
scribed by Dickson et al. (1992). The deletion mutant D-rafD445 was embryo per 1 ml (see Sprenger et al., 1993). Insoluble material was
generated by PCR using the oligos 5*-CCGCGGCCATGGCCA- removed by centrifugation at 47C for 10 min at 10,000g.
TGAGAGCAATAAAAATCTGC-3 * and 5*-GGCCCGACGTCG- D-raf protein was immunoprecipitated as described in Sprenger
CATGCTCCTCTAGACTCGAGG-3 * as the 5* and 3 * PCR prim- et al. (1993). Immunoprecipitates were resolved by 7.5% SDS±
ers, respectively. A 1.4-kb fragment was ampli®ed (35 cycles of PAGE and transferred to 0.2-mm-pore nitrocellulose membrane ®l-
947C, 1.0 min; 567C, 1.0 min; and 727C, 2.0 min), extracted with ters (Schleicher & Schuell) electrophoretically. These ®lters were
chloroform, ethanol precipitated, and subsequently digested with blocked with 2% bovine serum albumin (Sigma) in Tris-buffered
NcoI and EcoRI. The PCR fragment was gel puri®ed, extracted, and saline, pH 8.0 (TBS), for 1 hr, washed in TBST (TBS containing
ligated into gel-puri®ed pGEM7GLO which had been digested with 0.2% Tween 20), and probed for 2 hr with primary antibody diluted
NcoI and EcoRI. in TBST. The ®lters were then washed in TBST, incubated with a
horseradish peroxidase-coupled secondary antibody for 1 hr, and
In Vitro Transcription and Translation washed again in TBST. They were developed by using an enhanced
chemiluminescence system (Amersham) and visualized on KodakFor in vitro transcription, the template plasmid (pGEM7 / D-
raf cDNA) was puri®ed using the Plasmid Midi kit from Qiagen XAR-5 ®lm.
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FIG. 1. Linear representations of the primary amino acid structure for wild-type and modi®ed D-raf proteins. CR1 contains the putative
D-ras1 binding domain and a cysteine zinc ®nger-like motif, CR2 is rich in serines and threonines, and CR3 encodes the serine/threonine
kinase domain. Listed are the three amino acid substitutions used in this study and their positions within D-raf. In addition, three deletion
mutations of D-raf and a deleted, fusion D-raf protein targeted to the membrane by the signal sequence and extracellular and transmembrane
domains of the Tor protein are depicted. EC, extracellular domain; TM, transmembrane domain.
Densitometric analysis was performed on a Macintosh IIci com- protein from females with homozygous D-raf11-29 germlines
puter using the public domain NIH Image program (developed at (Figs. 3B±3F). In the absence of maternal D-raf, head and tail
the U.S. National Institutes of Health and available from the In- structures are not formed (Figs. 3B and 3E). After posterior
ternet by anonymous FTP from zippy.nimh.nih.gov or on ¯oppy injection of D-rafWT mRNA, rescue of pattern including Fil-
disk from the National Technical Information Service, Spring®eld, zkoÈ rper, tuft, and anal pads was observed (Fig. 3C). RescueVA, Part No. PB95-500195GEI).
of head structures was achieved when D-rafWT mRNA was
injected into the head region (Figs. 3D and 3F). In contrast,
injection of D-rafK497M mRNA encoding the kinase-defec-RESULTS tive form of D-raf into the anterior or posterior pole of the
embryo rescued neither head nor tail defects. The results
Kinase Activity of D-raf Is Essential for Its Role
in Terminal Development
To determine whether the Tor signal transduction path-
way could be reconstituted in embryos that lack maternal
D-raf protein, we microinjected mRNA encoding either a
wild-type D-raf (D-rafWT) or a kinase-defective mutant D-raf
(D-rafK497M) into embryos lacking maternal D-raf protein.
These embryos were derived from mothers homozygous
mutant for the D-raf 11-29 allele in their germlines (Chou
and Perrimon, 1992). Figure 1 shows a schematic represen-
FIG. 2. Accumulation of D-raf protein resulting from in vivotation of the wild-type D-raf and the mutant D-raf proteins
translation of wild-type D-raf mRNA after microinjection intoused in this analysis. mRNA was injected at a concentra-
embryos that lack maternal D-raf protein. (A) Accumulation oftion of approximately 1 mg/ml since this insured levels of
90-kDa D-raf protein in wild-type embryos. (B) No accumulationD-raf protein as high as those found in wild-type embryos
of D-raf protein is observed after injection of distilled water into(Fig. 2). After injection of D-rafWT or D-rafK497M mRNA,
embryos derived from females with homozygous D-raf11-29 germ-
embryos were allowed to develop for 24±48 hr, and ana- lines. (C±F) Accumulation of D-raf protein in embryos from D-
lyzed for the presence of terminal structures including raf 11-29 female germlines after injection of increasing concentra-
FilzkoÈ rper. tions of wild-type D-raf mRNA. Embryos injected with 0.75 mg/
Figure 3 shows cuticular preparations of a wild-type em- ml±1.0 mg/ml D-raf mRNA accumulate an essentially wild-type
level of D-raf protein.bryo (Fig. 3A) and mutant embryos that lack maternal D-raf
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FIG. 3. Induction of terminal structures in D-raf embryos that lack maternal D-raf protein after injection of wild-type D-raf mRNA.
Cuticular preparations of embryos are shown after the completion of embryonic development. (A) A wild-type embryo from a wild-type
mother with FilzkoÈ rper (arrow) and involuted head skeleton. (B) An embryo that lacks maternal D-raf protein, both head and tail structures
are deleted. (C) An embryo from a homozygous D-raf11-29 germline female after injection of wild-type D-raf mRNA showing rescue of
posterior terminal structures including FilzkoÈ rper (arrow). (D and F) Embryos from a homozygous D-raf11-29 germline female after injection
of D-raf mRNA showing rescue of head skeleton. (E) Truncated head skeleton of an embryo lacking maternal D-raf protein. db, dorsal
bridge; vpp, ventral posterior process.
of this analysis are summarized in Table 1. To con®rm the protein, as expected for D-raf, was synthesized (data not
shown). These results show that the kinase activity of D-integrity of the mRNAs used in this assay, D-raf mRNAs
were translated in rabbit reticulocyte lysates and a 90-kDa raf is essential for its function in the Tor signaling pathway.
TABLE 1
Microinjection of D-raf mRNA into Embryos that Lack Maternal D-raf Protein
Region No. of injected No. of embryos with Rescue of FilzkoÈ rper or Percentage
(egg length) D-raf mRNA embryos cuticlesa medial tooth rescue (%)
Posterior wild type 120 57 50 88%
(90±100%) K497M 199 75 0 0%
Anterior wild type 137 75 65 87%
(0±10%) K497M 178 64 0 0%
a Male embryos from D-raf mutant germlines do not develop cuticles. Percentage rescue refers only to those female embryos with
cuticles (see Materials and Methods).
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TABLE 2
Rescue of Embryos That Lack Maternal D-raf Protein by Wild-Type D-raf mRNA: Time Dependence
Nuclear cycle (NC) stages No. of developed embryos No. of embryos with cuticlesa Rescue of FilzkoÈ rper Percentage rescue (%)
NC 6±8 26 12 10 83%
NC 9±10 16 8 6 75%
NC 12±13 21 13 3 23%
NC14 20 10 0 0%
a The male embryos from D-raf mutant germlines do not develop cuticles. Percentage rescue refers only to those female embryos with
cuticles (see Materials and Methods).
Age-Dependent D-raf-Mediated Rescue conservation of structure among the components of this
signaling cascade such that activator(s) and substrate(s) ofTor protein ®rst appears at nuclear cycle 4 (NC 4) on the
D-raf are recognized by and can recognize human Raf-1 pro-surface of the embryonic membrane (Casanova and Struhl,
teins.1989) and zygotic tailless gene expression begins about 60
min later at NC 11 (Pignoni et al., 1990, 1992). It is during
this interval that activation of Tor and D-raf is required to
transduce the terminal signal from the membrane into nu- Identi®cation of D-raf Phosphorylation Sites
clei at the embryonic poles. To determine when activation
of D-raf is required to transmit the Tor signal, D-rafWT Phosphorylation may be a mechanism by which the activ-
ity of D-raf is regulated. Maternal D-raf protein becomesmRNA at 1 mg/ml was injected into embryos that lack ma-
ternal D-raf protein. When embryos were injected at NC phosphorylated 2 hr after fertilization in wild-type embryos
(Sprenger et al., 1993). At this time the Tor RTK has been6±8 or NC 9±10, 83 and 75% of the embryos developed
FilzkoÈ rper, respectively (Table 2). However, at NC 12±13 activated and the intracellular signal generated for zygotic
expression of tailless. Morrison et al. (1993) have identi®edthe percentage rescue was dramatically reduced (23%) and
at NC 14 after the onset of cellularization none of the in- the major phosphorylation sites of the Raf-1 kinase in mam-
malian and recombinant baculoviral-infected Sf9 insectjected embryos developed FilzkoÈ rper. Sprenger and NuÈ ssl-
ein-Volhard (1992) observed a similar age-dependent rescue cells. Sequence comparison reveals that two of these phos-
phorylation sites (S259 and S621) and the residues sur-of tor mutant embryos after the injection of tor mRNA.
This experiment indicates that the optimal period of activa- rounding these serines (RSXSXP) are conserved in all Raf
family members, indicating that these sites of phosphoryla-tion and signal transduction by D-raf in the Tor pathway is
between NC 6 and 12. For the experiments described below, tion may be required for the enzymatic activity or regula-
tion of the Raf kinases. These serine residues correspond tomRNAs were injected into embryos at stages NC 6±9 of
embryonic development. S388 and S743 of the D-raf protein.
To determine whether S388 and S743 are in vivo sites of
D-raf phosphorylation, wild-type and mutant D-raf proteins
Mammalian Raf-1 Proteins Can Substitute for with serine to alanine substitutions (S388A and S743A)
D-raf in the Tor RTK Pathway were labeled with [32P]orthophosphate in Sf9 cells. The la-
beled D-raf proteins were immunoprecipitated from cell ly-Since there is 45% amino acid homology between D-raf
and Raf-1 (Mark et al., 1987; Nishida et al., 1988), we tested sates, separated by electrophoresis on SDS±polyacrylamide
gels, extracted, digested with trypsin, and the phosphopep-the ability of human Raf-1 to act in the Drosophila Tor
signal transduction pathway. In this experiment, 1 mg/ml in tides were analyzed by two-dimensional peptide mapping
(Fig. 4). For D-rafWT ®ve labeled peptides were observedvitro synthesized Raf-1 mRNA (Fabian et al., 1993) was
injected into the posterior of embryos lacking maternal D- (Figs. 4A and 4D). For the altered D-raf proteins D-rafS388A
(Fig. 4B) and D-rafS743A (Fig. 4C), phosphopeptides A and B,raf protein. After injection, 70 embryos developed, and of
these 4 embryos showed terminal FilzkoÈ rper (5.7% rescue). respectively, were absent. This analysis indicates that ser-
ine residues 388 and 743 serve as putative D-raf phosphory-Thus, Raf-1 can interact at low ef®ciency with Drosophila
proteins in the Tor pathway. We also tested whether a lation sites in Sf9 cells and suggests that these sites may
also be phosphorylation sites in the Drosophila embryo. Inhighly transforming N-terminal deletion of human Raf-1,
Raf-1D305 (Samuels et al., 1993), could substitute for D-raf addition, since the phosphopeptide map of kinase-defective
D-rafK497M is identical to that of D-rafWT, it is unlikely thatin embryos that lack maternal D-raf activity. In this case,
11% rescue of FilzkoÈ rper was achieved after injection of 1 the phosphorylated peptides result from D-raf autophos-
phorylation (data not shown).mg/ml Raf-1D305 mRNA. These results indicate that there is
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FIG. 4. Two dimensional phosphopeptide maps of wild-type and D-raf proteins with serine to alanine substitutions. In vivo 32P-labeled
D-raf proteins isolated from Sf9 cells were digested with trypsin and resolved in two dimensions on TLC plates by electrophoresis (vertical
axis) and by chromatography (horizontal axis). (A) For D-rafWT ®ve labeled phosphopeptides, depicted as phosphopeptides A±E (D), are
observed. (B) For D-rafS388A labeled phosphopetide B is absent. (C) For D-rafS743A phosphopeptide A is absent while those for B (arrow) and
C±E are present. (D) Schematic representation of the ®ve wild-type D-raf phosphopeptides.
Signaling Activity of D-raf Proteins with Serine to mRNAs encoding these and D-rafS388A/S743A double mutant
proteins were injected into the posterior of embryos lackingAlanine Substitutions
maternal D-raf protein (see Fig. 1). After 48 hr embryos wereTo determine whether substitution of alanine at serine
scored for the presence of FilzkoÈ rper (Table 3). After injec-phosphorylation site 388 or 743 alters the ability of D-raf to
tion with D-rafS388A mRNA, rescue of posterior pattern wasparticipate in the Tor pathway, 1 mg/ml in vitro synthesized
observed (Fig. 5A) at a level similar to that of D-rafWT
mRNA (78 compared to 88%). However, D-rafS743A (Fig. 5B)
and the double mutant D-rafS388A/S743A mRNAs failed to pro-
mote the formation of terminal structures. Rescue of headTABLE 3
structures was also observed after anterior injection ofMicroinjection of mRNAs Encoding Serine to Alanine-Substituted,
D-rafS388A but not with D-rafS743A or D-rafS388A/S743A mRNAsN-Terminal-Deleted and a Membrane-Targeted D-raf into the
(data not shown). Thus, the presence of a serine or phosphor-Posterior Region of Embryos Lacking Maternal D-raf Protein
ylation at site 743 is essential for D-raf to propagate the Tor
No. of No. of signal. In contrast, lack of a serine and/or phosphorylation
injected embryos with Rescue of Percentage at residue 388 does not interfere with D-raf's ability to act
D-raf mRNA embryos cuticlesa FilzkoÈ rper rescue (%) in the Tor pathway.
S388A 143 80 62 78%
S743A 196 92 0 0%
Activity of N-Terminal-Deleted and Membrane-S388A/S743A 151 83 0 0%
Associated Forms of D-rafD-rafD315 153 86 49 57%
D-rafD370 120 68 37 54% Amino-terminal truncations of Raf-1 are transforming,
D-rafD445 160 95 90 95% the result of constitutive activation of Raf-1 kinase activity
D-raftor4021 85 51 47 92%
(Bonner et al., 1985; Rapp et al., 1988). Thus, removal of
these residues relieves Raf-1 from negative regulationa Male embryos from D-raf mutant germlines do not develop
cuticles (Materials and Methods). (Heidecker et al., 1990). We tested whether D-raf proteins
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FIG. 5. Development of D-raf embryos that lack maternal D-raf protein after posterior injection of modi®ed D-raf mRNAs. Cuticular
preparations of embryos are shown after the completion of embryonic development. (A) Rescue of posterior FilzkoÈ rper (arrow) after injection
of D-rafS388A mRNA. (B) Terminal rescue is not observed after injection of D-rafS743A mRNA. (C) Rescue of posterior FilzkoÈ rper (arrow)
after injection of D-rafD315 mRNA. (D) Rescue of posterior FilzkoÈ rper (arrow) after injection of D-rafD445 mRNA. (E) Rescue of posterior
FilzkoÈ rper (arrow) after injection of D-raf tor4021 mRNA. (F) For some embryos after injection of D-raf tor4021 mRNA the region containing
the anal plates was enlarged (arrow) and this expansion was accompanied by deletion of part or all of abdominal segment eight.
having N-terminal truncations would substitute for wild- Raf-1 kinase (Leevers et al., 1994; Stokoe et al., 1994).
Therefore, we tested a deletion mutation, D-raf tor4021, whichtype D-raf in the Tor pathway (see Fig. 1). For this analysis
three deletions of D-raf were tested, D-rafD315, D-rafD370, and encodes the CR2 and CR3 sequences equivalent to D-rafD370
fused to the signal sequence and extracellular and trans-D-rafD445. D-rafD315 lacks CR1, which contains the putative
Ras-1 binding domain and the cysteine ®nger region. D- membrane domains of the Tor protein (see Fig. 1). In D-
raf tor4021, the extracellular domain of Tor has a substitutionrafD370 lacks CR1 and part of CR2, but retains the rest of
CR2 and the serine/threonine kinase domain (CR3). D- of cysteine for tyrosine at position 327 that renders the
protein constitutively active (Sprenger and NuÈ sslein-Volh-rafD445 encodes only CR3. As shown in Table 3, when 1
mg/ml of each of these deleted forms of D-raf mRNAs was ard, 1992). This fusion protein has previously been shown
to induce R7 development in the Sevenless/D-ras1 signalinjected into the posterior of embryos lacking maternal D-
raf protein, greater than 50% rescue of FilzkoÈ rper was transduction pathway in the absence of Sevenless RTK ac-
tivity (Dickson et al., 1992).achieved. Figures 5C and 5D show two embryos that lack
maternal D-raf protein after injection of D-rafD370 and D- When 1 mg/ml of D-raf tor4021 mRNA was injected into the
posterior of embryos that lack maternal D-raf protein, res-rafD445 mRNAs, respectively. Both embryos show rescue of
posterior pattern. Rescue of head structures was also ob- cue of posterior FilzkoÈ rper was observed. However, in these
experiments many of the embryos produced weak cuticlesserved after anterior injection of D-rafD315, D-rafD370, and
D-rafD445 mRNAs (data not shown). These results indicate that ruptured during the process of mounting. Other em-
bryos had cuticles that appeared faint or crinkled in whichthat N-terminal-truncated D-raf molecules can recognize
and interact with their substrate(s) to transmit the Tor sig- terminal as well as abdominal structures were dif®cult to
score. Therefore, we tested the effect of microinjection us-nal in embryos.
It has also been shown that targeting Raf-1 to the plasma ing 0.25 mg/ml of D-raf tor4021 mRNA. As shown in Table 3,
rescue of FilzkoÈ rper was observed for 92% of the injectedmembrane results in a Ras-independent, active form of the
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ml only 10% rescue of FilzkoÈ rper was observed. Thus, it
appears that there is a threshold level of wild-type activity
required to achieve a high degree of terminal rescue. To
determine the relative biological activity of wild-type and
mutant D-raf mRNAs, we calculated the approximate con-
centration of mRNA needed for injection to achieve 80%
terminal rescue. For D-rafWT approximately 0.76 mg/ml
mRNA would be required. Similarly, to achieve 80% rescue
the approximate concentration of mRNA required for injec-
tion of D-rafD445 is 0.097 mg/ml mRNA, while for D-rafS388A
0.030 mg/ml mRNA is required, and for D-raf tor4021 0.002 mg/
ml mRNA is required (Fig. 6). Using these calculations, the
biological activity of D-rafD445 mRNA is approximately 7.5-
fold greater than wild-type, while D-rafS388A and D-raf tor4021
FIG. 6. Comparison of the relative biological activity of wild-type
and mutant D-raf mRNAs. Percentage posterior rescue for embryos
that lack maternal D-raf protein after injection of D-rafWT, D-
rafD445, D-rafS388A, or D-raf tor4021 mRNA at various mRNA concen-
trations. A similar volume of mRNA was injected into each embryo
and at each mRNA concentration more than 50 embryos with de-
veloped cuticles were scored.
embryos, and very few embryos produced weak cuticles.
An example of a rescued embryo is depicted in Fig. 5E.
Interestingly, a second effect of D-raf tor4021 was observed,
and this is shown in Fig. 5F (arrows). For some embryos
the region containing the anal plates was enlarged and this
expansion was accompanied by deletion of part or all of
abdominal segment eight, which is also speci®ed by the Tor
pathway. Thus, unlike wild-type, D-rafS388A, or D-rafD445
proteins, expression of D-raf tor4021 in some embryos directed
the formation of an altered posterior pattern. Rescue of head
structures was also observed after anterior injection of
D-raf tor4021 mRNA (data not shown).
Relative Biological Activity of Wild-Type and
Mutant D-raf mRNAs
Since serine substitution at S388A, amino-terminal trun-
cation, and membrane targeting may affect regulation of
and signaling by D-raf, we determined the relative biological FIG. 7. Accumulation of D-raf protein produced in vivo after mi-
croinjection of D-raf mRNAs into embryos that lack maternal D-activity and rescuing potential of wild-type, D-rafS388A, D-
raf protein. For each sample, 100 embryos were injected, allowedrafD445, and D-raf tor4021 mRNAs (Fig. 6). In these experiments
to develop for 60 min, and then processed for Western analysis.a similar volume of mRNA was injected into each embryo
(A) Western blot of D-rafWT, D-rafS388A, D-rafD445, and D-raf tor4021and at each mRNA concentration tested more than 50 em-
proteins that accumulate after injection of 1 mg/ml of the corre-bryos with developed cuticles were scored.
sponding D-raf mRNA. By comparison, the accumulation of D-For wild-type mRNA, posterior rescue was the highest
rafS388A is approximately one-half, that of D-rafD445 is approximately
after injection of 1 mg/ml mRNA (99%). At lower mRNA twice, and that of D-raf tor4021 is approximately equivalent to the
concentrations the percentage of embryos that showed pos- level observed for D-rafWT. (B) Accumulation of D-raf tor4021 protein
terior rescue declined. After injection of approximately 0.71 after injection of 0.125, 0.25, 0.50, and 1.0 mg/ml D-raf tor4021 mRNA.
and 0.50 mg/ml wild-type D-raf mRNA, 76 and 70% rescue Densitometric analysis was performed using NIH Image 1.56 (see
Materials and Methods).was achieved, respectively, while at approximately 0.36 mg/
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mRNAs are 25-and 380-fold more active, respectively, than ing of ligand molecules to receptor tyrosine kinases that
dimerize, leading to their transphosphorylation on tyrosinewild-type D-raf mRNA.
Since less than wild-type levels of mRNA were required residues (see van der Greer et al., 1994). These phosphotyro-
sines then serve as attachment sites for the adapter protein,to achieve a high percentage of embryonic rescue, the con-
centration of each mutant protein produced in vivo was Drk, which recruits the guanine nucleotide-releasing factor
Son of Sevenless (SOS) to form the membrane-associateddetermined. Figure 7A shows the results of this experiment,
in which embryonic lysates were compared after injection activating complex for Ras. In turn, Ras promotes Raf mem-
brane association, and this complex phosphorylates and ac-of 1 mg/ml D-rafWT, D-rafS388A, D-rafD445, or D-raf tor4021
mRNA. For each sample, 100 embryos were injected, al- tivates MEK, a protein kinase with dual speci®city (see Mar-
shall, 1995). MEK then activates MAPK, which is thenlowed to develop for 60 min, and then processed for Western
analysis. The relative level of each mutant protein synthe- translocated to the nucleus where it phosphorylates tran-
scription factors that regulate gene expression. In the casesized was determined by comparing its level of accumula-
tion to that found after injection of 1 mg/ml wild-type D-raf of the Tor pathway, an unknown transcription factor(s) is
responsible for expression of the terminal zygotic genesmRNA. For D-rafS388A, a 90-kDa D-raf protein accumulates
at a concentration of approximately one-half that observed tailless and huckebein (see Lu et al., 1993b). Additional
complexity in Tor signaling has been reported by Hou etfor the wild-type D-raf protein. After injection of D-rafD445
mRNA, a truncated D-raf protein less than 45 kDa was al. (1995), because activation of D-raf by Tor can occur in
a D-ras1-independent manner.produced at a level 2-fold greater than that found for wild-
type D-raf. Finally, as predicted, a greater than 116-kDa
protein accumulated after injection of D-raf tor4021 mRNA at
Serine/Threonine Kinase Activity of D-rafa level approximately equal to that found for D-rafWT pro-
Is Essential for Tor Signal Transductiontein. In Fig. 7B, we also show that after injection of 0.125±
1.0 mg/ml of D-raf tor4021 mRNA there was a gradual increase It has been previously shown that D-raf autophosphory-
lates and acts as a serine/threonine kinase in vitro whenin the amount of D-raf tor4021 protein synthesized in vivo.
Similar results were achieved for D-rafS388A and D-rafD445 incubated with Mn2/ and [32P]ATP (Sprenger et al., 1993).
In addition, Melnick et al. (1993) showed that two muta-mRNAs (data not shown). Thus, in these experiments an
equivalent amount of D-raf tor4021, one-half the quantity of tions of D-raf that gave a null phenotype in the Tor pathway
were associated with single amino acid substitutions withinD-rafS388A and 2-fold more D-rafD445 protein accumulated
compared to wild-type. If protein concentration is then conserved regions of the D-raf kinase domain. These two
®ndings strongly indicate that D-raf functions as a serine/taken into consideration when calculating biological activ-
ity, D-raf tor4021 mRNA is 380-fold more active, D-rafS388A threonine kinase in Drosophila and that this activity is re-
quired for Tor signal transduction. However, a kinase-de-mRNA is 50-fold more active, and D-rafD445 mRNA is four
times as active as wild-type D-raf mRNA. pendent as well as an independent requirement, related to
subcellular localization and/or participation in a multipro-
tein complex, has been shown for the Drosophila Abelson
tyrosine kinase (Henkemeyer et al., 1988, 1990). Here weDISCUSSION
show directly that a point mutation known to inactivate
the D-raf serine/threonine kinase in vitro (Sprenger et al.,The Tor pathway is activated when the Drosophila em-
bryo is a syncytium. As a large single cell, the Drosophila 1993) also abrogates the ability of the protein to act in the
Tor pathway in vivo. Thus, D-raf's kinase activity is essen-embryo is easily amenable to phenotypic rescue by microin-
jection. Since mutations in various gene products of the tial for D-raf function in Tor signal transduction.
Tor pathway have been characterized they serve as good
backgrounds in which to add wild-type or mutant D-raf
Conservation of Structure and Function of Signalproteins and to assay the activity of altered signaling com-
Transduction Moleculesponents. Thus, we have used the Tor signal transduction
pathway to test the function of modi®ed D-raf proteins in In order to test the evolutionary conservation of the Tor
signal transduction pathway, we tested whether human Raf-an in vivo developmental context. D-raf mutations were
generated to address the mechanism(s) that regulates its 1 could substitute for D-raf in Drosophila embryos. Full-
length human Raf-1 replaced D-raf in the Tor pathway atkinase activity or facilitates access to its substrate(s). This
system offers a rapid approach for structure/function analy- low ef®ciency, but the highly transforming N-terminal-de-
leted form of Raf-1 was twice as active. Overall, these re-sis of the Raf family of serine/threonine kinases as well
as other molecules that participate in the evolutionarily sults show that there is structural conservation between
the components of this signaling cascade and that activa-conserved signaling module utilized by receptor tyrosine
kinases for transmission of cellular signals (see Perrimon, tor(s) and substrate(s) of D-raf are recognized by and can
recognize the human Raf-1 proteins. Therefore, it is likely1993).
In general, signal transduction begins following the bind- that we can use the genetics of Drosophila to gain a better
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understanding of the mechanisms utilized for signal trans- the truncated D-raf molecules recognize, have access to,
and can interact with the substrate(s) of the full-length wild-duction as it pertains to the control of growth and develop-
ment in higher organisms. type D-raf protein. This result is signi®cant because we
show that truncated forms of D-raf can act in the absence
of and independent of wild-type D-raf. Thus, oncogenic
Phosphorylation as a Mechanism for D-raf forms of Raf-1 may act in a similar manner in mammalian
Regulation cells that contain wild-type Raf-1 proteins.
Next, we addressed the effect on Tor signal transduc-Protein kinases and phosphatases play a critical role as
mediators in signal transduction pathways. Reversible pro- tion of a membrane-targeted N-terminal-truncated D-raf.
In mammalian cells, targeting of Raf-1 to the plasmatein phosphorylation is a good mechanism by which to regu-
late developmental choices. Indeed, it has recently been membrane results in a Ras-independent, active form of
the Raf-1 kinase (Leevers et al., 1994; Stokoe et al., 1994).shown that reversal of Raf-1 activation is achieved by puri-
®ed and membrane-associated protein phosphatases (Dent D-raftor4021, a chimeric D-raf protein used in this study, is
directed to the membrane through the Tor signal se-et al., 1995). Two putative phosphorylation sites have been
mapped for the D-raf kinase isolated from Sf9 cells, serine quence and was shown to induce R7 development in the
Sevenless/D-ras1 signal transduction pathway in the ab-residues S388 and S743. These two residues and sur-
rounding residues (RSXSXP) are conserved among members sence of Sevenless RTK activity (Dickson et al., 1992).
Thus, this chimeric form of D-raf probably has constitu-of the Raf family of protein kinases and correspond to ser-
ines 259 and 621 of the Raf-1 protein (Morrison et al., 1993). tive activity in all cell types in which it is expressed. Here
we test whether D-raftor4021 can substitute for wild-typeSince phosphorylation occurs at these sites for the kinase-
defective D-rafK497M protein, these events are not due to D-raf and transmit the Tor signal in the absence of mater-
nal D-raf protein. We ®nd that D-raftor4021 promotes forma-autophosphorylation and appear to be dependent upon an-
other kinase(s). These results suggest that in Drosophila tion of terminal structures and at high concentrations can
cause the expansion of some posterior elements withinembryos, these sites are potentially important for the regu-
lation of D-raf activity. the terminal domain. This result indicates that higher
than wild-type levels of D-raf activity are produced by D-Substitution of an alanine at residue S743 rendered the
D-raf protein inactive, while substitution at site S388 was raftor4021 and is consistent with the idea that D-raftor4021
acts constitutively in the Tor signaling pathway.permissive and resulted in rescue of the D-raf maternal ef-
fect. This result is consistent with that observed for Raf-1
when the homologous amino acid substitutions were
Relative Biological Activity of Wild-Type andtested. In in vitro kinase assays Raf-1S621A had no activity,
Mutant D-raf mRNAswhile Raf-1S259A showed a threefold increase in kinase activ-
ity compared to that of wild-type Raf-1 (Morrison et al., The maternal terminal system de®nes the spatial expres-
sion patterns of the tailless (tll) and huckebein (hkb) genes.1993). Unlike wild-type Raf-1, Raf-1S259A did not associate
with 14-3-3 and showed Ras-independent enzymatic activ- Transcriptional activation of tll requires a low level of D-
raf activity and occurs in nuclei that lie within the presump-ity as assayed by the induction of meiotic maturation in
Xenopus oocytes (Michaud et al., 1995). It is likely that tive tail region, at 0±20% egg length. High levels of D-raf
activity promote hkb expression and are restricted to nucleifunctional conservation at these two phosphorylation sites
is indicative of an evolutionarily conserved mechanism that at 0±12% egg length (Melnick et al., 1993). In this study we
de®ne rescue of the Tor pathway by scoring development ofmodulates Raf activity. Thus, phosphorylation could serve
to alter the conformation of the Raf protein, its enzymatic FilzkoÈ rper that require tll, but not hkb expression (Weigel
et al., 1989). However, many of the rescued embryos containactivity, its interactions with other molecules, or a combi-
nation of these modi®cations. pattern elements that are induced by hkb expression (Baek
and Ambrosio, unpublished data). Although we assay bio-
logical function of D-raf simply at the activity level that
Regulation of N-Terminal Deletion Mutants triggers tll expression, in many embryos it is probable that
of D-raf expression of hkb is also induced.
When the biological activity of D-rafWT was characterizedIn mammalian cells, N-terminal truncation of Raf-1 leads
to increased Raf-1 kinase activity and oncogenic transfor- at low concentrations of D-raf mRNA (0.36 mg/ml), 10% of
the injected embryos developed FilzkoÈ rper. However, at amation (Stanton et al., 1989; Heidecker et al., 1990). Here,
we tested whether truncated versions of D-raf can substi- slightly higher concentration (0.5 mg/ml) 72% rescue of Fil-
zkoÈ rper was observed. This indicates that there is a criticaltute for full-length D-raf and transmit the Tor signal in
embryos that lack maternal D-raf protein. We tested three threshold of D-raf activity required to promote FilzkoÈ rper
formation. At twice this concentration (1.0 mg/ml) 99% ofdifferent N-terminal deletions, each encoding the D-raf ki-
nase domain, that effectively participated in signal trans- the embryos developed FilzkoÈ rper. We designated 80% res-
cue as a good measure of D-raf biological function and thenduction. These results indicate that at least a fraction of
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compared the concentration of wild-type and modi®ed as wild-type D-raf protein to the membrane, this question
may be addressed. Further characterization of these modi-forms of D-raf mRNA required to achieve this level of
rescue. ®ed forms of D-raf in embryos lacking the activity of up-
stream pathway components will provide additional cluesWhen the relative biological activity of each modi®ed
form of D-raf was determined in vivo and normalized for toward understanding the mechanisms utilized in wild-type
cells to promote transduction of a signal from the mem-protein concentration, the activity of D-raf tor4021 mRNA
was 380-fold greater, D-rafS388A mRNA was 50-fold more brane to the nucleus.
active, and D-rafD445 mRNA was four times as active as
wild-type D-raf mRNA. These differences in biological ac-
tivity levels are likely related to the structural and confor- ACKNOWLEDGMENTS
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